1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Chemotherapy Induced Peripheral Neuropathy Market – By Drug Class

1.3.2        North America Chemotherapy Induced Peripheral Neuropathy Market – By Distribution Channel

1.3.3        North America Chemotherapy Induced Peripheral Neuropathy Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Chemotherapy Induced Peripheral Neuropathy Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           North America Chemotherapy Induced Peripheral Neuropathy Market Dynamics

5.1         Market Drivers

5.1.1        Raising Prevalence of Cancer

5.1.2        Surging Preference for Chemotherapy

5.2         Market Restraints

5.2.1        Limited Consolidated Guidelines for Chemotherapy

5.3         Future Trends

5.3.1        Burgeoning Clinical Trials for Chemotherapeutic Drugs

5.4         Impact Analysis

6.           North America Chemotherapy Induced Peripheral Neuropathy Market Analysis

6.1         North America Chemotherapy Induced Peripheral Neuropathy Market Revenue Forecast And Analysis

7.           North America Chemotherapy Induced Peripheral Neuropathy Market – by Drug Class

7.1         Overview

7.2         Drug Class Market Revenue and Forecast Analysis (US$ Million)

7.3         Steroids

7.3.1        Overview

7.3.2        Steroids Revenue and Forecast to 2028 (US$ Million)

7.4         Antidepressants

7.4.1        Overview

7.4.2        Antidepressants Revenue and Forecast to 2028 (US$ Million)

7.5         Anti-seizure

7.5.1        Overview

7.5.2        Anti-seizure Revenue and Forecast to 2028 (US$ Million)

7.6         Narcotics

7.6.1        Overview

7.6.2        Narcotics Revenue and Forecast to 2028 (US$ Million)

8.           North America Chemotherapy Induced Peripheral Neuropathy (CIPN) Market – by Distribution Channel

8.1         Overview

8.2         Distribution Channel Market Revenue and Forecast Analysis (US$ Million)

8.3         Hospital Pharmacy

8.3.1        Overview

8.3.2        Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Million)

8.4         Retail Pharmacy

8.4.1        Overview

8.4.2        Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Million)

8.5         Online Pharmacy

8.5.1        Overview

8.5.2        Online Pharmacy Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Chemotherapy Induced Peripheral Neuropathy Market – Country Analysis

9.1         Overview

9.1.1        North America: Chemotherapy Induced Peripheral Neuropathy Market, by Country, 2021 & 2028 (%)

9.1.1.1          US: Chemotherapy Induced Peripheral Neuropathy Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1          US: Chemotherapy Induced Peripheral Neuropathy Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2          US: Chemotherapy Induced Peripheral Neuropathy Market, by Drug Class, 2019–2028 (US$ Million)

9.1.1.1.3          US: Chemotherapy Induced Peripheral Neuropathy Market, by Distribution Channel, 2019–2028 (US$ Million)

9.1.1.2          Canada: Chemotherapy Induced Peripheral Neuropathy Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1          Canada: Chemotherapy Induced Peripheral Neuropathy Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.2          Canada: Chemotherapy Induced Peripheral Neuropathy Market, by Drug Class, 2019–2028 (US$ Million)

9.1.1.2.3          Canada: Chemotherapy Induced Peripheral Neuropathy Market, by Distribution Channel, 2019–2028 (US$ Million)

9.1.1.3          Mexico: Chemotherapy Induced Peripheral Neuropathy Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1          Mexico: Chemotherapy Induced Peripheral Neuropathy Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.2          Mexico: Chemotherapy Induced Peripheral Neuropathy Market, by Drug Class, 2019–2028 (US$ Million)

9.1.1.3.3          Mexico: Chemotherapy Induced Peripheral Neuropathy Market, by Distribution Channel, 2019–2028 (US$ Million)

10.        North America Chemotherapy Induced Peripheral Neuropathy Market– Industry Landscape

10.1      Overview

10.2      Organic Developments

10.2.1     Overview

10.3      Inorganic Developments

10.3.1     Overview

11.        Company Profiles

11.1      REGENACY PHARMACEUTICALS, INC.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Asahi Kasei Pharma Corporation

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      MAKScientific, LLC

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      WEX Pharmaceuticals Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Sova Pharmaceuticals, Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Kineta, Inc.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Aptinyx Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Apexian Pharmaceuticals, Inc.

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      WinSanTor, Inc.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Overview

11.9.4     SWOT Analysis

11.9.5     Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Chemotherapy Induced Peripheral Neuropathy Market, by Drug Class – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Chemotherapy Induced Peripheral Neuropathy Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Canada: Chemotherapy Induced Peripheral Neuropathy Market, by Drug Class – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Canada Chemotherapy Induced Peripheral Neuropathy Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Mexico: Chemotherapy Induced Peripheral Neuropathy Market, by Drug Class – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Mexico Chemotherapy Induced Peripheral Neuropathy Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Organic Developments Done By Companies

Table 8.             Inorganic Developments Done By Companies

Table 9.             Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Chemotherapy Induced Peripheral Neuropathy Market Segmentation

Figure 2.           North America Chemotherapy Induced Peripheral Neuropathy Market, By Country

Figure 3.           North America Chemotherapy Induced Peripheral Neuropathy Market Overview

Figure 4.           Steroids Segment Held Largest Share of Drug Class Segment in Chemotherapy Induced Peripheral Neuropathy Market

Figure 5.           The US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America Chemotherapy Induced Peripheral Neuropathy Market, Industry Landscape

Figure 7.           North America: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           Impact Analysis of Drivers and Restraints Pertaining to Chemotherapy Induced Peripheral Neuropathy Market

Figure 10.        North America Chemotherapy Induced Peripheral Neuropathy Market– Revenue Forecast And Analysis – 2020- 2028

Figure 11.        Drug Class Market Analysis and Forecast 2021 and 2028 (%)

Figure 12.        Steroids Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Antidepressants Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Anti-seizure Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Narcotics Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Distribution Channel Market Analysis and Forecast 2021 and 2028 (%)

Figure 17.        Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Online Pharmacy Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America: Chemotherapy Induced Peripheral Neuropathy Market, by Key Country – Revenue (2021) (US$ Million)

Figure 21.        North America: Chemotherapy Induced Peripheral Neuropathy Market, by Country, 2021 & 2028 (%)

Figure 22.        US: Chemotherapy Induced Peripheral Neuropathy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Canada: Chemotherapy Induced Peripheral Neuropathy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Mexico: Chemotherapy Induced Peripheral Neuropathy Market – Revenue and Forecast to 2028 (US$ Million)